Erschienen in:
01.12.2015 | ORIGINAL ARTICLE
Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature
verfasst von:
Yasuo Shima, Takehiro Okabayashi, Akihito Kozuki, Tatsuaki Sumiyoshi, Teppei Tokumaru, Yuichi Saisaka, Keiichi Date, Jun Iwata
Erschienen in:
Langenbeck's Archives of Surgery
|
Ausgabe 8/2015
Einloggen, um Zugang zu erhalten
Abstract
Purpose
There are no accepted surgical strategies for the treatment of pancreatic cancer recurrence in the remnant pancreas after initial resection. We retrospectively analyzed our experiences with patients undergoing completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas.
Methods
Six patients with recurrent pancreatic cancer in the remnant pancreas underwent completion pancreatectomy between March 2005 and December 2012. Operative, postoperative, and pathological data and long-term outcomes for these six patients were analyzed retrospectively.
Results
There was no operative morbidity or mortality associated with completion pancreatectomy. The median survival times were 49.0 and 27.5 months after initial resection and second pancreatectomy, respectively. However, all six patients died during follow-up. Five patients had recurrent pancreatic cancer at the time of death. One patient had no recurrence but had poor blood sugar control and eventually died after repeated bouts of cholangitis.
Conclusions
Completion pancreatectomy is a safe and effective option in select patients with local pancreatic cancer recurrence in the remnant pancreas after initial pancreatectomy. It is essential to select patients who have a good performance status and can tolerate major surgery and the resultant apancreatic state.